Table 1 Potential therapeutic targets against M. pachydermatis.

From: New Therapeutic Candidates for the Treatment of Malassezia pachydermatis -Associated Infections

EC Number

Abbreviature

Enzyme

Human Match

% Protein similarity

4.2.1.19

IGPD

Imidazoleglycerol-phosphate dehydratase

NA

NA

2.5.1.78

RIBH

6,7-Dimethyl-8-ribityllumazine synthase

NA

NA

2.5.1.9

RIB

Riboflavin synthase

NA

NA

2.3.3.14

HCS

Homocitrate synthase

HMGCL

14.4

1.1.1.3

HSD

homoserine dehydrogenase

PSB5

18.31

1.5.1.7; 1.5.1.10

SDH

Saccharopine dehydrogenase

F8WE53

19.71

4.2.1.36

HACN

Homoaconitate hydratase

ACON

21.36

1.1.1.41; 1.1.1.42

IDH

Isocitrate dehydrogenase

IDH3A

32.72

1.14.13.70

CYP51A1

Lanosterol 14 alpha-demethylase

CP51A

36.48

2.7.4.22

UK

Uridylate kinase

KCY

40.7

1.3.1.-

ERG4/ERG24

Ergosterol biosynthesis sterol reductase ERG4/ERG24

LBR

41.18

5.4.2.8

PMM

Phosphomannomutase

H3BV55

51.06

6.4.1.1

PC

Pyruvate carboxylase

PC

51.43

3.6.1.9

ITPA

Inosine triphosphate pyrophosphatase

ITPA

52.91

6.3.4.5

AS

Argininosuccinate synthase

ASSY

55.3

  1. The in-silico deletion of these enzymes resulted in a decrease in the production of biomass of at least 30%. The percentage of similarity and human match to the human proteome is also shown. Prioritized enzymes are shown in bold and underline.